Advertisement
Advertisement
RKDA
Arcadia Biosciences, Inc.
1.07
USDSponsored
-0.03
-2.73%
May 08, 15:45 UTC -4
Closed
After-Market
1.07
0.00
+0.47%
RKDA Earnings Reports
Positive Surprise Ratio
RKDA beat 22 of 38 last estimates.
58%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.94M
/-$0.57
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
+33.20%
/-2950.00%
Arcadia Biosciences, Inc. earnings per share and revenue
On May 06, 2026, RKDA reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.81 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.63 million, with a --% difference.
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.57 USD, with revenue projected to reach 1.94 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Werewolf Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+3.68%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
FAQ
What were Arcadia Biosciences, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Arcadia Biosciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Arcadia Biosciences, Inc.'s Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Arcadia Biosciences, Inc. expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Arcadia Biosciences, Inc.'s next earnings report?
Based on 3
analysts, Arcadia Biosciences, Inc. is expected to report EPS of -$0.57 and revenue of $1.94M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement